SPOTLIGHT: Health plans target off-label use

Particularly given the rise of ultra-high-cost biologic drugs and other pricey treatments, health plans are intensifying their efforts to cut pharma costs. One way they're doing so, it seems, is to crack down on off-label prescribing, limiting coverage to only FDA-approved use for such drugs. The question, doctors say, is what to do if they believe that an off-label use is in their patient's best interest. Article